⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylamine SCHEMBL1256243 | 1.00 | — | — | |
| Ethylamine SCHEMBL18863917 | 0.94 | — | — | |
| Ethylamine SCHEMBL1793 | 0.93 | — | — | |
| Ethylamine SCHEMBL854887 | 0.93 | — | — | |
| Ethylamine SCHEMBL1331327 | 0.93 | — | — | |
| Ethylamine SCHEMBL16986062 | 0.88 | — | — | |
| Ethylamine SCHEMBL11239451 | 0.88 | DNM1 (0.35) | — | |
| Ethylamine SCHEMBL11239448 | 0.88 | DNM1 (0.35) | — | |
| Ethylamine SCHEMBL126107 | 0.86 | — | — | |
| Ethylamine SCHEMBL1048625 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080167364-A1 | RAMIPRIL-AMINE SALTS | SELAMINE LIMITED (IE) | 2008-07-10 | — | — | US | claimed |
| WO-2008065431-A1 | RAMIPRIL-AMINE SALTS | SELAMINE LTD (IE) | 2008-06-05 | — | — | WO | claimed |
| US-20240175019-A1 | Skeletal Muscle Delivery Platforms and Methods of Use | Arrowhead Pharmaceuticals, Inc. | 2024-05-30 | — | — | US | disclosed |
| US-20230265429-A1 | SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE THEREOF | Arrowhead Pharmaceuticals, Inc. | 2023-08-24 | — | — | US | disclosed |
| CN-116490214-A | Skeletal muscle delivery platform and method of use | 箭头药业股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
| EP-4210763-A1 | SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4210713-A1 | SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4210759-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-116348150-A | Lipid conjugates for delivery of therapeutic agents | 箭头药业股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116323633-A | Skeletal muscle delivery platform and method of use | 箭头药业股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022056273-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2014064427-A1 | LOW REFRACTIVE INDEX PARTICLES | OXFORD ENERGY TECHNOLOGIES LIMITED (GB) | 2014-05-01 | — | — | WO | disclosed |
| WO-2014016608-A1 | RADIATION CURABLE OPTICAL COATING | OXFORD ENERGY TECHNOLOGIES LIMITED (GB) | 2014-01-30 | — | — | WO | disclosed |
| US-20130216807-A1 | OPTICAL COATING COMPRISING POROUS SILICA NANOPARTICLES | OXFORD ENERGY TECHNOLOGIES LIMITED (GB) | 2013-08-22 | — | — | US | disclosed |
| EP-2606388-A1 | OPTICAL COATING COMPRISING POROUS SILICA NANOPARTICLES | Oxford Energy Technologies Ltd. (GB) | 2013-06-26 | — | — | EP | disclosed |
| WO-2012022983-A1 | OPTICAL COATING COMPRISING POROUS SILICA NANOPARTICLES | OXFORD ENERGY TECHNOLOGIES LIMITED (GB) | 2012-02-23 | — | — | WO | disclosed |
| US-20080167364-A1 | RAMIPRIL-AMINE SALTS | SELAMINE LIMITED (IE) | 2008-07-10 | — | — | US | disclosed |
| WO-2008065431-A1 | RAMIPRIL-AMINE SALTS | SELAMINE LTD (IE) | 2008-06-05 | — | — | WO | disclosed |